Global NASH Biomarker Market
(2016 - 2024)
Global Growth Hormone Deficiency Market is expected to register a CAGR of 4.20% during the assessment period of 2020 to 2027, to reach USD 5,243.3 Million by 2027.
The growth of the Global Growth Hormone Deficiency Market is expected to be driven by the increasing number of individuals suffering from Growth Hormone Deficiency (GHD), rising awareness regarding the effectiveness of growth hormone along with clinical trials focused on the safety and efficacy of GHD, and the changing lifestyle along with the growing prevalence of genetic disorders. However, the high cost of treatment and increasing counterfeit products being used for the treatment are restraining the market growth. On the other hand, the collaboration of major players with small players, coupled with the rise in the innovation marked by prominent players, poses lucrative opportunities for the global growth hormone deficiency market.